Research Tracker›Biomarker Atlas›Marker Pages›Insulin-like Growth Factor-1 (IGF-1)

Insulin-like Growth Factor-1 (IGF-1): biomarker evidence

Insulin-like Growth Factor-1 (IGF-1) appears in 1 entry of the OSMF biomarker atlas, covering Major Depressive Disorder. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Major Depressive Disorder

Where Insulin-like Growth Factor-1 (IGF-1) is reported

ConditionDirectionCompared againstAssociated symptomsSource
Major Depressive Disorder↑ elevatedhealthy controls—Arinami et al. 2023

Frequently asked questions

In which conditions is Insulin-like Growth Factor-1 (IGF-1) altered?

In the OSMF atlas Insulin-like Growth Factor-1 (IGF-1) is reported in Major Depressive Disorder. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Insulin-like Growth Factor-1 (IGF-1)?

The atlas entries for Insulin-like Growth Factor-1 (IGF-1) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Insulin-like Growth Factor-1 (IGF-1) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Insulin-like Growth Factor-1 (IGF-1) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/insulin-like-growth-factor-1-igf-1.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.